Allison Lullo

Partner Litigation

New York +1 212 446 4965

Allison Lullo

Overview

Allison Lullo is a partner in the Government, Regulatory & Internal Investigations Group in the New York office of Kirkland & Ellis LLP. Allison advises companies and their officers and directors in a wide variety of U.S. DOJ, SEC, and CFTC investigations, internal investigations, and compliance matters, with a focus on securities, futures, and derivative financial product enforcement, as well as anti-corruption and anti-bribery, securities fraud, accounting fraud, insider trading, and financial statement and disclosure issues. Additionally, Allison regularly counsels clients regarding workplace misconduct and compliance issues.

Allison was previously seconded to a leading multinational financial services firm, where she assisted with regulatory inquiries and exams, with a focus on futures and swaps products.

Allison’s representative matters at Kirkland and another leading international law firm have included:

Government, Regulatory & Internal Investigations

  • Represented multinational financial institution in DOJ market manipulation investigation.
  • Represented multinational financial institution in CFTC investigation into swap data reporting compliance.
  • Represented fund and fund trader in CFTC and CME investigations into alleged spoofing and market manipulation.
  • Represented multinational financial services firms in responding to regulatory inquiries in connection with equities and derivatives trading.
  • Represented fund in SEC insider trading investigation.
  • Represented publicly-traded automotive company in DOJ and SEC investigations involving allegations of securities fraud.
  • Represented board of directors of construction company in SEC investigation involving allegations of accounting fraud.
  • Advised publicly-traded manufacturing company in connection with internal investigation into potential accounting fraud.
  • Advised board of directors of healthcare provider in connection with internal investigation into allegations of workplace misconduct by CEO.

 Anti-Corruption & International Risk

  • Represented multinational medical device company in DOJ and SEC FCPA investigation involving allegations of misconduct across Europe, Asia, and Latin America.
  • Advised multinational medical device company in connection with internal investigation into bribery and corruption at foreign subsidiary.
  • Conducted anti-corruption risk assessments and developed and implemented FCPA compliance programs for multinational corporations with operations in high risk countries and industries, including medical device, biotechnology, and oil and gas sectors.
  • Advised private equity firms and their portfolio companies on FCPA and international risk matters.

Associate, Ropes & Gray LLP, 2011–2017

Assistant Attorney General, New York State Attorney General’s Office, 2010–2011

More

Thought Leadership

Publications 

Co-author, “CFTC 2018 Enforcement: Where the Puck Is Going,” New York Law Journal (January 26, 2018)

Co-author, “SEC’s Focus On Financial Reporting: Recent Cases And Trends,” Law360 (November 30, 2016)

Co-author: “U.S. Anti-corruption Enforcement Priorities: Three Key Risk Areas for 2015,” Corporate Disputes (April 2015)

Co-author, “Settlement of Major Healthcare Fraud Enforcement Proceedings: A Probing and Frank Analysis of The Competing Variables,” The Health Lawyer (February 2013)

“Leaving Behind a Good Idea: How No Child Left Behind Fails to Incorporate the Individualized Spirit of the I.D.E.A.,” The George Washington Law Review (February 2010)

Credentials

Admissions & Qualifications

  • 2011New York
  • 2011Massachusetts

Languages

  • Spanish

Education

  • The George Washington University Law SchoolJ.D.with Honors2010

    Notes Editor, The George Washington Law Review

  • Lafayette CollegeB.A., Law and Philosophy & Spanishsumma cum laude2007

    Phi Beta Kappa